EGFR and breast cancer: The HER2/neu (ErbB) oncogene family plays a significant role in the growth, development, and metastasis of several tumor types, including ovarian and breast cancer, and its early expression in BC is associated with a significantly increased risk of cancer recurrence post-treatment [120].